Clinton Health Access Initiative, Inc.’s Post

Do you know that Pediatric HIV refers to children who are infected with the Human Immunodeficiency Virus (HIV). HIV can be acquired during pregnancy, childbirth, or through breastfeeding if the mother is living with HIV. Children with HIV require special care and support to manage their condition effectively. Pediatric HIV can present unique challenges compared to HIV in adults. Their immune systems are still developing, making them more vulnerable to infections and illnesses. Early diagnosis is crucial to start treatment as soon as possible and minimize potential complications. Antiretroviral therapy (ART) plays a vital role in the treatment of pediatric HIV. ART helps to suppress the virus, improve the child's immune system, and enable them to live healthier lives. Treatment regimens for children may differ from those for adults, taking into account factors such as weight, age, and developmental stages. #care4hivchildren

Retesting for HIV emerges as a pivotal strategy in prevention of new child infections. As we adhere to MoH guidelines on MR, we take significant efforts toward creating zero transmission of HIV from mother-to-child.

Maternal Retesting (MR), refers to the practice of conducting additional HIV tests during pregnancy and breastfeeding period if the initial antenatal care test was negative. Retesting for HIV emerges as a pivotal strategy in prevention of new child infections. As we adhere to MoH guidelines on MR, we take significant efforts toward creating zero transmission of HIV from mother-to-child. Why MR is important? > HIV seroconversion during pregnant increases risk of mother-to-child transmission. >Mother-to-child transmission is higher among women with new HIV infection. >HIV acquisition risk is higher in pregnancy. MR algorithm, >1st test- done at first ANC booking( recommended within 12 weeks). > 2nd test- done at (32-36 weeks) of gestation age. > 3rd test- done at 3 months after delivery. > 4th test - done at 6 months after delivery. > 5th test( the last ) - done at 18 months after delivery. # “Communities and countries and ultimately the World are only as strong as the health of their women.” — Michelle Obama

South Central AIDS Education & Training Center (SCAETC) Training slides- Breastfeeding in HIV These slides review the risk of #HIV transmission via breast milk and offer recommendations for #breastfeeding women with HIV. https://lnkd.in/eMx_NcgZ #WomensHistoryMonth #BreastfeedingMom

🛑 Asthma's Impact on Paediatric HIV Patients, What You Should Know! 👌Beneath the surface of pediatric HIV treatment is a hidden battle: the increased frequency of asthma. Today, we'll explore the lives of these young fighters and the unforeseen problems they encounter. Join us on a trip of attention-grabbing insights. ✅ Recent study revealed that the children born to HIV-positive parents, particularly those treated with HAART, had a higher asthma prevalence (10.4% vs 3.8%). Let's break down the ramifications, delving into the complexities of this critical research that spans the pre- and post-HAART periods. ↪️ Zooming in on Detroit, Michigan, new data from an HIV-positive pediatric group portrays a similar trend. 28% of the children, aged 3 to 16, fulfilled asthma criteria, although specifics about HAART treatment are unclear. 🛑 The link is undeniable: pediatric HIV patients have asthma, and it's time to shed attention on their secret battles. 👌Empathy is a tremendous force. Share this article to raise awareness of the issues that pediatric HIV patients encounter while coping with asthma. Let us create a helpful community. someone who needs to be educated, and let's start a ripple of compassion. #CRK #CRO #Kenya #pediatrichealth #HIVandasthma, #pediatricstruggles #clinicalresearchinsights #healthawareness

South Central AIDS Education & Training Center (SCAETC) Training slides- Breastfeeding in HIV These slides review the risk of #HIV transmission via breast milk and offer recommendations for #breastfeeding women with HIV. https://lnkd.in/eAtSpc7D #WomensHistoryMonth #BreastfeedingMom

Dispatches from #IAS2023: While antiretroviral therapy has helped reduce the transmission of #HIV from moms to babies, challenges remain in providing the best care to pregnant and breastfeeding women and their newborns, especially in resource-constrained environments. The session “Advancing HIV care for mothers and newborns: Exploring long-acting solutions,” examined the potential for advancing newborn care using long-acting HIV prevention and treatment options, which offer simpler and more convenient alternatives to current treatments. The hold-up? Limited research into their safety and effectiveness. “Despite the advances in HIV care and treatment for adults, treatment options for infants continue to depend on first-generation antiretroviral therapies such as Nevirapine,” said MSH’s Shamim Nakade from the USAID/Strengthening Supply Chain Systems Activity in #Uganda, led by MSH. “With nearly 50% of HIV mother-to-child transmissions occurring during breastfeeding, ongoing studies on long-acting interventions for infants will go a long way toward bridging the treatment gap.” #MSHatIAS2023 

CIPHER Grant Programme 2023/2024 Important Date: Deadline Date: October 31, 2023 Donor Name: International AIDS Society Grant Size: $100,000 to $500,000 Category: Grant Reference URL: https://lnkd.in/dykT3AzW The Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Grant Programme funds projects with the potential to address research gaps in paediatric and adolescent HIV in countries with limited resources for HIV research.

Startling Revelation: The Link Between HIV and Asthma in Paediatric Patients 👌 The Hidden Connection: Asthma Increases in HIV-Positive Children. Excellent Numbers Have Been Revealed! Prepare for a surprise beyond pediatric health. ↪️ In the post-HAART era, pioneering research has shown a startling association between HIV and asthma in children. Hold tight as we delve into this surprising relationship's astounding data and possible ramifications. ✅ Dive inside the halls of clinical research as we look at a critical study done at Texas Children's Hospital in 2005. Asthma prevalence among HIV-seropositive persons aged 1-24 increased to 34%, compared to 2.9% among demographically comparable HIV-negative adults. 💥 Surprisingly, 75% of these young children were on HAART treatment when they were diagnosed with asthma, indicating a possible link with immunological restoration. ↪️ Also, Retrospective research from 1988 to 2006 found that HIV-positive children treated with HAART had a significantly higher frequency of asthma than those who did not. The figures tell a story: 33.5% vs 11.5%. Buckle up as we explore these surprising discoveries that shed light on the complexities of pediatric HIV treatment. 🤝 Let's start meaningful talks! Please share your opinions on the confluence between HIV and pediatric asthma. Are these results just the tip of the iceberg? 👌Join us as we pave the road for a better understanding of these health processes. Comment below and tag someone who should know! #health #pediatricresearch #pediatrichealth #HIV #Asthma #ClinicalResearch #CRK #CRO

Congressional Briefing: Syndemic Approaches to Ending the HIV, Hepatitis, and STI Epidemics Date: June 27, 2024 Time: 3:00 PM – 4:00 PM Location: 385 Russell Senate Office Building, 2 Constitution Avenue NE, Washington, DC 20002 RSVP: Email Zach Miller, Policy Manager, NMAC, ZMiller@NMAC.org The session will cover: Syndemic approaches to our HIV, STI, and viral hepatitis epidemics Current funding levels and their impact Evidence-based needs, effective syndemic policies, and proposed budget allocations The implications of the appropriations on public health outcomes